Brooke Austen: ICON hosted event to discuss common challenges faced by the biotech industry
“Great opportunity for Biotech in Boston to have productive interaction with ICON plc Biotech team and discuss truly important steps on leveraging AI and building value proposition early during clinical development.”
Quoting ‘s post:
“We would like to invite you to join us at Legal Sea Foods for an ICON hosted event to discuss common challenges faced by the biotech industry. This event promises to offer valuable insights and networking opportunities that can help you stay ahead in this competitive market. Our esteemed speakers, including Travis Caudill and Christopher O’Toole, will deliver great presentations while you enjoy some delicious food and drinks. Kerri Eckelman, Vanessa Weston, Charlene Zebrowski, Lyn Cappel, Dave Pope, Chris Smyth, Greg Licholai, and Beth Moeller will also be in attendance. ”
Source:
Tanja Obradovic is the Vice President of Oncology Scientific Affairs at ICON PLCh. She has over 20 years of clinical research experience and has led major pharmaceutical companies for 13 years. Her research focuses on small molecules, antibodies, cell and gene therapy, and major immunotherapy of PD1 inhibitors.